Healthcare Leaders Confront Monopolies at HLTH 2024 Conference

At the HLTH 2024 conference, industry leaders discussed the challenges posed by monopolistic practices in American healthcare, highlighting the dominance of a few large entities that restrict competition and drive up costs. A panel titled “Owning Healthcare’s Boardwalk” examined the role of antitrust regulations and asserted that current policies, including restrictions on Medicare price negotiations and oversight of hospital mergers, have exacerbated this issue. Dr. Robert Pearl outlined five ways these practices have adversely affected patients, particularly through high drug prices, inadequate oversight of hospital mergers, and the influence of pharmacy benefit managers on drug access.

Opens on Robert Pearl